Prof. Abd Al Magid Tahrani
Abd Tahrani is a National Institute for Health Research (NIHR) Clinician Scientist at the University of Birmingham (UoB), an Honorary Consultant Endocrinologist at the University Hospitals of Birmingham NHS Foundation Trust, the lead for weight management research and diabetic neuropathy services at Birmingham Heartlands Hospital, the lead for translational research in the Centre of Endocrinology, Diabetes and Metabolism (CEDAM), Birmingham Health Partners and the communication co-lead in the Institute of Metabolism and Systems Research (IMSR) at the UoB. He obtained his PhD in 2013 from the UoB, which was focussed on the impact of obstructive sleep apnoea (OSA) in patients with Type 2 diabetes, and was awarded a SCOPE National Fellowship in 2014 from the World Obesity Federation. Abd’s research has the following themes: the metabolic consequences of sleep-related disorders, obesity management and complications, diabetes-related neuropathy, and the pharmacology of type 2 diabetes and obesity. Abd has published over 130 peer reviewed articles, and delivered more than 70 invited talks in the internationally leading conferences in the field. He was awarded the American Academy of Sleep Medicine Sleep Disordered Breathing investigator of the year award in 2013 and two awards from the NIHR in the UK in 2008 and 2013 amongst several other awards. Abd is an elected member of Neurodiab, a trustee of the Association for the Study of Obesity ASO (UK), a panel member of the NIHR Research for Patients Benefit (RfPB), the NIHR Dissemination Centre, the program organising committee of European Congress of Obesity 2019, and the British Sleep Society Research Committee, and an Expert advisor to the Medical Technology Advisory Committee of NICE and the chair for the obesity management committee in the ASO (UK). He is a regular peer reviewer to the leading journals in medicine, sleep, obesity, diabetes and endocrinology and multiple national and international research funding organisations.